Literature DB >> 203657

Observations on the growth and plaque assay of BK virus in cultured human and monkey cells.

J Seehafer, P Carpenter, D N Downer, J S Colter.   

Abstract

Although human embryo kidney (HEK), muscle (HEM) and lung (HEL) cells are capable of supporting the replication of BK virus (BKV) through passage levels 9, 12 and 12 respectively, only third, fourth and fifth passage level HEK cells were found to be satisfactory for the plaque assay of the virus. BSC-I and VERO cells can also be used for the plaque assay of BKV. However, in HEK cells plaques can be visualized in 20 days (compared to 28 days in BSC-I cells), and since in VERO cells the plaques are poorly defined and the titre about I log10 lower than in either HEK or BSC-I cells, HEK cells were the ones chosen for use.

Entities:  

Mesh:

Year:  1978        PMID: 203657     DOI: 10.1099/0022-1317-38-2-383

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  4 in total

1.  Ether lipid ester derivatives of cidofovir inhibit polyomavirus BK replication in vitro.

Authors:  Parmjeet Randhawa; Noush Afarin Farasati; Ron Shapiro; Karl Y Hostetler
Journal:  Antimicrob Agents Chemother       Date:  2006-04       Impact factor: 5.191

2.  Rapid detection of polyomavirus BK by a shell vial cell culture assay.

Authors:  W F Marshall; A Telenti; J Proper; A J Aksamit; T F Smith
Journal:  J Clin Microbiol       Date:  1990-07       Impact factor: 5.948

3.  Rapid detection and identification of JC virus and BK virus in human urine by using immunofluorescence microscopy.

Authors:  T F Hogan; B L Padgett; D L Walker; E C Borden; J A McBain
Journal:  J Clin Microbiol       Date:  1980-02       Impact factor: 5.948

Review 4.  Viral indicators for tracking domestic wastewater contamination in the aquatic environment.

Authors:  Kata Farkas; David I Walker; Evelien M Adriaenssens; James E McDonald; Luke S Hillary; Shelagh K Malham; Davey L Jones
Journal:  Water Res       Date:  2020-05-10       Impact factor: 11.236

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.